Monthly
US$200
Billed every month
Sign in to subscribeFerrous Succinate Tablets
As of 13 November 2026, for Ferrous Succinate Tablets, 20 applications are listed as under review at China's CDE; 12 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 15 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 3 applicationsNo longer listed under review: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders15View records ↓
Under-review filings20View records ↓
This year’s generic filers12View records ↓
NHSA approval numbers16View records ↓
API companies with A status8View records ↓
Chemical-drug catalogue
Loaded records: 15 holders; 4 in the quality-and-efficacy consistency-evaluation category, and 9 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20265853 | 2026/09/02 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20265277 | 2026/07/21 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20265019 | 2026/06/30 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Si Li An Pharma Co., Ltd. romanized | Beijing Si Li An Pharma Co., Ltd. romanized | 国药准字H20264043 | 2026/04/21 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Jia He Pharma Co., Ltd. romanized | Anhui Jia He Pharma Co., Ltd. romanized | 国药准字H20264045 | 2026/04/21 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Rui Yang Pharmaceutical Co., Ltd. romanized | Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20263716 | 2026/03/25 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20256310 | 2025/12/16 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Huayi Pharmaceuticals (Anhui) Co., Ltd. | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20256304 | 2025/12/16 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Zhong Tian Pharma Co., Ltd. romanized | Jiangsu Zhong Tian Pharma Co., Ltd. romanized | 国药准字H20255296 | 2025/09/02 | 0.1g | Other drug | CDE |
| Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20249775 | 2024/12/25 | 0.1g | Other drug | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | 2024/09/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 2023/08/02 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20133230 | 2022/11/18 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hunan Jiudian Pharmaceutical Co., Ltd | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 2022/06/09 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H10930005 | 2022/01/28 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 16 distinct approval numbers and 16 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Si Li An Pharma Co., Ltd. romanized | 国药准字H20264043 | 0.1g | Category A | XB03AAH026A001010100011 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010100177 | NHSA |
| Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20249775 | 0.1g | Category A | XB03AAH026A001010100475 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20265019 | 0.1g | Category A | XB03AAH026A001010101503 | NHSA |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H10930005 | 0.1g | Category A | XB03AAH026A001010101529 | NHSA |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 0.1g | Category A | XB03AAH026A001010102118 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20263716 | 0.1g | Category A | XB03AAH026A001010104152 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20265277 | 0.1g | Category A | XB03AAH026A001010104647 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20133230 | 0.1g | Category A | XB03AAH026A001010104929 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001010104942 | NHSA |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20265853 | 0.1g | Category A | XB03AAH026A001010104960 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20256310 | 0.1g | Category A | XB03AAH026A001010180698 | NHSA |
| Jiangsu Zhong Tian Pharma Co., Ltd. romanized | 国药准字H20255296 | 0.1g | Category A | XB03AAH026A001010181457 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010184691 | NHSA |
| Anhui Jia He Pharma Co., Ltd. romanized | 国药准字H20264045 | 0.1g | Category A | XB03AAH026A001010185179 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010200177 | NHSA |
| Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20249775 | 0.1g | Category A | XB03AAH026A001010200475 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20265019 | 0.1g | Category A | XB03AAH026A001010201503 | NHSA |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H10930005 | 0.1g | Category A | XB03AAH026A001010201529 | NHSA |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 0.1g | Category A | XB03AAH026A001010202118 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20265277 | 0.1g | Category A | XB03AAH026A001010204647 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20133230 | 0.1g | Category A | XB03AAH026A001010204929 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001010204942 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20256310 | 0.1g | Category A | XB03AAH026A001010280698 | NHSA |
| Jiangsu Zhong Tian Pharma Co., Ltd. romanized | 国药准字H20255296 | 0.1g | Category A | XB03AAH026A001010281457 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20256304 | 0.1g | Category A | XB03AAH026A001010284212 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010284691 | NHSA |
| Anhui Jia He Pharma Co., Ltd. romanized | 国药准字H20264045 | 0.1g | Category A | XB03AAH026A001010285179 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010300177 | NHSA |
| Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20249775 | 0.1g | Category A | XB03AAH026A001010300475 | NHSA |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H10930005 | 0.1g | Category A | XB03AAH026A001010301529 | NHSA |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 0.1g | Category A | XB03AAH026A001010302118 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20265277 | 0.1g | Category A | XB03AAH026A001010304647 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20133230 | 0.1g | Category A | XB03AAH026A001010304929 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001010304942 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20256310 | 0.1g | Category A | XB03AAH026A001010380698 | NHSA |
| Jiangsu Zhong Tian Pharma Co., Ltd. romanized | 国药准字H20255296 | 0.1g | Category A | XB03AAH026A001010381457 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20256304 | 0.1g | Category A | XB03AAH026A001010384212 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010384691 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010400177 | NHSA |
| Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20249775 | 0.1g | Category A | XB03AAH026A001010400475 | NHSA |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H10930005 | 0.1g | Category A | XB03AAH026A001010401529 | NHSA |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 0.1g | Category A | XB03AAH026A001010402118 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20265277 | 0.1g | Category A | XB03AAH026A001010404647 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001010404942 | NHSA |
| Jiangsu Zhong Tian Pharma Co., Ltd. romanized | 国药准字H20255296 | 0.1g | Category A | XB03AAH026A001010481457 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010484691 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010500177 | NHSA |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H10930005 | 0.1g | Category A | XB03AAH026A001010501529 | NHSA |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 0.1g | Category A | XB03AAH026A001010502118 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001010504942 | NHSA |
| Jiangsu Zhong Tian Pharma Co., Ltd. romanized | 国药准字H20255296 | 0.1g | Category A | XB03AAH026A001010581457 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010584691 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010600177 | NHSA |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 0.1g | Category A | XB03AAH026A001010602118 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001010604942 | NHSA |
| Jiangsu Zhong Tian Pharma Co., Ltd. romanized | 国药准字H20255296 | 0.1g | Category A | XB03AAH026A001010681457 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010684691 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010700177 | NHSA |
| Chengdu Ao Bang Pharma Co., Ltd. romanized | 国药准字H20083003 | 0.1g | Category A | XB03AAH026A001010702118 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010784691 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | See source | Category A | XB03AAH026A001010800177 | NHSA |
| Guangzhou Shi Yi Yuan Pharmaceuticals Co., Ltd. romanized | 国药准字H20264714 | See source | Category A | XB03AAH026A001010884691 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001020104942 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001020704942 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001020804942 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20193239 | 0.1g | Category A | XB03AAH026A001030104942 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 20 filings and 20 distinct first applicants.
Generic 19 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Jiangsu Run Heng Pharmaceutical Co., Ltd. romanized | CYHS2504452 | Generic | 2025/12/29 | Not stated by source | CDE |
| TC Pharmaceuticals (Jiangsu) Co., Ltd | CYHS2602118 | Generic | 2026/08/25 | Not stated by source | CDE |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | CYHB2601431 | Supplement | 2026/07/24 | Not stated by source | CDE |
| Zhejiang Qian Jin Pharma Co., Ltd. romanized | CYHS2601997 | Generic | 2026/08/13 | Not stated by source | CDE |
| Anhui Zheng Yao Pharmaceuticals Technology Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2601935 | Generic | 2026/08/07 | Not stated by source | CDE |
| Chongqing Xi Er An Pharma Co., Ltd. romanized; Chongqing Guo Tai Kang Ning Pharmaceutical Co., Ltd. romanized | CYHS2601757 | Generic | 2026/07/22 | Not stated by source | CDE |
| Lin Fen Bao Zhu Pharmaceutical Co., Ltd. romanized | CYHS2601649 | Generic | 2026/07/09 | Not stated by source | CDE |
| Zhejiang He Li Xin Jian Pharma Co., Ltd. romanized | CYHS2601433 | Generic | 2026/06/17 | Not stated by source | CDE |
| Kunming Yuan Rui Pharmaceutical Co., Ltd. romanized | CYHS2600954 | Generic | 2026/04/24 | Not stated by source | CDE |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | CYHS2600868 | Generic | 2026/04/15 | Not stated by source | CDE |
| Beijing Ren Zhong Pharma Co., Ltd. romanized | CYHS2600404 | Generic | 2026/02/07 | Not stated by source | CDE |
| Zhejiang Yuan Li Jian Pharma Co., Ltd. romanized | CYHS2600370 | Generic | 2026/02/05 | Not stated by source | CDE |
| Tianjin Bai Hai Pharma Co., Ltd. romanized | CYHS2600087 | Generic | 2026/01/08 | Not stated by source | CDE |
| Shanxi Bao Tai Pharma Co., Ltd. romanized | CYHS2504518 | Generic | 2025/12/31 | Not stated by source | CDE |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | CYHS2502145 | Generic | 2025/06/17 | Not stated by source | CDE |
| Shaanxi Ju Cheng Biopharmaceuticals Manufacturing Li Cu Jin Center Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2501589 | Generic | 2025/04/28 | Not stated by source | CDE |
| Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CYHS2501379 | Generic | 2025/04/10 | Not stated by source | CDE |
| Shanxi Tong Da Pharma Co., Ltd. romanized | CYHS2501200 | Generic | 2025/03/27 | Not stated by source | CDE |
| Shanghai Jin Bu Huan Lan Kao Pharmaceutical Co., Ltd. romanized | CYHS2501199 | Generic | 2025/03/27 | Not stated by source | CDE |
| Chengdu Ke Lai Meng Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | CYHS2602669 | Generic | 2026/11/02 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 12 filings and 12 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| TC Pharmaceuticals (Jiangsu) Co., Ltd | CYHS2602118 | Generic | 2026/08/25 | Not stated by source | CDE |
| Zhejiang Qian Jin Pharma Co., Ltd. romanized | CYHS2601997 | Generic | 2026/08/13 | Not stated by source | CDE |
| Anhui Zheng Yao Pharmaceuticals Technology Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2601935 | Generic | 2026/08/07 | Not stated by source | CDE |
| Chongqing Xi Er An Pharma Co., Ltd. romanized; Chongqing Guo Tai Kang Ning Pharmaceutical Co., Ltd. romanized | CYHS2601757 | Generic | 2026/07/22 | Not stated by source | CDE |
| Lin Fen Bao Zhu Pharmaceutical Co., Ltd. romanized | CYHS2601649 | Generic | 2026/07/09 | Not stated by source | CDE |
| Zhejiang He Li Xin Jian Pharma Co., Ltd. romanized | CYHS2601433 | Generic | 2026/06/17 | Not stated by source | CDE |
| Kunming Yuan Rui Pharmaceutical Co., Ltd. romanized | CYHS2600954 | Generic | 2026/04/24 | Not stated by source | CDE |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | CYHS2600868 | Generic | 2026/04/15 | Not stated by source | CDE |
| Beijing Ren Zhong Pharma Co., Ltd. romanized | CYHS2600404 | Generic | 2026/02/07 | Not stated by source | CDE |
| Zhejiang Yuan Li Jian Pharma Co., Ltd. romanized | CYHS2600370 | Generic | 2026/02/05 | Not stated by source | CDE |
| Tianjin Bai Hai Pharma Co., Ltd. romanized | CYHS2600087 | Generic | 2026/01/08 | Not stated by source | CDE |
| Chengdu Ke Lai Meng Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | CYHS2602669 | Generic | 2026/11/02 | Not stated by source | CDE |
API registrations
Non-component matches: 8 companies with A status and 3 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 琥珀酸亚铁 · No verified English name | Hubei Heng Di Pharma Co., Ltd. romanized | Y20260000780 | I | Exact ingredient | 2026/09/10 | CDE |
| 琥珀酸亚铁 · No verified English name | Henan You Kai Pharmaceutical Co., Ltd. romanized | Y20260000213 | I | Exact ingredient | 2026/03/30 | CDE |
| 琥珀酸亚铁 · No verified English name | Rui Yang Pharmaceutical Co., Ltd. romanized | Y20250000535 | I | Exact ingredient | 2025/06/04 | CDE |
| 琥珀酸亚铁 · No verified English name | Chi Zhou Dong Sheng Pharma Co., Ltd. romanized | Y20230001367 | A | Exact ingredient | 2025/05/20 | CDE |
| 琥珀酸亚铁 · No verified English name | Lian Yun Gang Gui Ke Pharma Co., Ltd. romanized | Y20230000866 | A | Exact ingredient | 2025/09/11 | CDE |
| 琥珀酸亚铁 · No verified English name | Xuan Cheng Mei Nuo Hua Pharma Co., Ltd. romanized | Y20220000178 | A | Exact ingredient | 2024/01/31 | CDE |
| 琥珀酸亚铁 · No verified English name | Jin Hong Pharma Co., Ltd. romanized | Y20210000267 | A | Exact ingredient | 2023/08/24 | CDE |
| 琥珀酸亚铁 · No verified English name | Hunan Hua Na Da Pharmaceutical Factory Shou Xing Drug Co., Ltd. romanized | Y20190008919 | A | Exact ingredient | 2023/04/19 | CDE |
| 琥珀酸亚铁 · No verified English name | Chengdu Ao Bang Pharma Co., Ltd. romanized | Y20190005747 | A | Exact ingredient | 2025/09/16 | CDE |
| 琥珀酸亚铁 · No verified English name | Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | Y20190003584 | A | Exact ingredient | 2024/12/28 | CDE |
| 琥珀酸亚铁 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20170001256 | A | Exact ingredient | 2025/04/03 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/12No longer listed under review
Jiangxi Tai Ji Li Biopharmaceuticals Technology Co., Ltd. romanized; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized
CYHS2500733
Fact date: 2026/11/12 · Site observation date: 2026/11/12
Accepted: 2025/02/13
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/02Accepted
Chengdu Ke Lai Meng Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized
CYHS2602669
Fact date: 2026/11/02 · Site observation date: 2026/11/03
View source ↗ -
2026/10/26Marketing application approved
Chi Feng Gu De Pharma Co., Ltd. romanized
CYHS2404279 · 国药准字H20266409
Fact date: 2026/10/26 · Publication date: 2026/10/27 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 21 ↗ -
2026/09/09Accepted
An Shi Pharmaceutical (Zhong Shan) Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd.
CYHB2601708
Fact date: 2026/09/09 · Site observation date: 2026/10/22
View source ↗ -
2026/08/25Accepted
TC Pharmaceuticals (Jiangsu) Co., Ltd
CYHS2602118
Fact date: 2026/08/25 · Site observation date: 2026/10/21
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Ferrous Succinate Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy